In Vitro Fertilization: Clinical Trials

7 trials for In Vitro Fertilization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Terminated 7

Follow In Vitro Fertilization: new trials by email Literature Review of In Vitro Fertilization trials Research Report on In Vitro Fertilization

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles
Progesterone 25 MG subcutaneous, Micronized progesterone 200 MG, recombinant FSH - Infertility, In Vitro Fertilization
Phase 4TerminatedAndros Day Surgery Clinic602016-12-202020-01-10
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
rFSH, buserelin - In Vitro Fertilization, Ovarian Stimulation
Phase 4TerminatedAndros Day Surgery Clinic1942013-03-012016-12-23
Delayed Start to Ovarian Stimulation
Ganirelix acetate - Diminished Ovarian Reserve, Infertility
Phase 4TerminatedUniversity of California, San Francisco302012-05-012021-06-15
Cetrotide Treatment Optimization
Cetrotide (Ovarian stimulation) - In Vitro Fertilization, Intracytoplasmic Sperm Injection
Phase 4TerminatedBart CJM Fauser6172009-02-012014-03-19
Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)
Mild stimulation - in Vitro Fertilization, Ovulation Induction
Phase 4TerminatedUMC Utrecht1472009-01-012019-01-29
A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)
Ovarian stimulation - In Vitro Fertilization
Phase 4TerminatedBart CJM Fauser342008-10-012013-07-22
EXpression PRofile Endometrium Samples Study
Gonal -f® [r-hFSH], Ovitrelle® [r-hCG alfa], Gonadotropin-releasing hormone (GnRH) Agonist - In Vitro Fertilization
Phase 4TerminatedMerck KGaA, Darmstadt, Germany272008-08-012013-12-27

Narrower conditions

Infertility (3)  ·  Aneuploidy (1)

Broader conditions

Genital Diseases (3)  ·  Urogenital Diseases (3)  ·  Chromosome Aberrations (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

follitropin alfa (3)  ·  ganirelix (3)  ·  Ovulation Induction (2)  ·  cetrorelix (2)  ·  follitropin beta (2)  ·  Buserelin (1)  ·  Chorionic Gonadotropin (1)  ·  Glycoprotein Hormones, alpha Subunit (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Injections, Subcutaneous (1)  ·  Ovidrel (1)  ·  Progesterone (1)  ·  Triptorelin Pamoate (1)

Sponsors

Andros Day Surgery Clinic (2)  ·  Bart CJM Fauser (2)  ·  Merck KGaA, Darmstadt, Germany (1)  ·  UMC Utrecht (1)  ·  University of California, San Francisco (1)

Countries

Netherlands (3)  ·  Italy (2)  ·  Belgium (1)  ·  France (1)  ·  United States (1)

Top investigators

Nick S Macklon, Prof, PhD (2)  ·  Adolfo Allegra, MD (1)  ·  Bart C Fauser, Prof, PhD (1)  ·  Mitchell Rosen, MD (1)

Results publications

PMID 23809501, PMID 24129613, PMID 24929258